The economic costs of Crohn’s disease and ulcerative colitis

The Economic Costs of Crohn’s Disease and Ulcerative Colitis landmark 2007 study commissioned by CCA and conducted by Deloitte Access Economics revealed the (then) $2.7 billion annual cost of Crohn’s disease and ulcerative colitis in Australia.

The report detailed the financial costs and economic burden caused by these chronic illnesses.

The study also recommends a strategy to reduce the costs associated with IBD and enhance the quality and options for care and disease management.